New advances in severe adverse drug reactions (Q34436490)

2 August 2017

1 reference

title

New advances in severe adverse drug reactions (English)

1 reference

2 August 2017

Revuz J

1

1 reference

2 August 2017

publication date

1 October 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

19

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

697-709, ix

1 reference

The use of skin testing in the investigation of cutaneous adverse drug reactions

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Hypersensitivity syndrome due to 2 anticonvulsant drugs.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8 lymphocyte involvement

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Adverse drug reactions: definitions, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Selective generation of CD8 T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

High-dose trimethoprim-sulfamethoxazole therapy with corticosteroids in previously intolerant patients with AIDS-associated Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Thalidomide Promotes the Release of Tumor Necrosis Factor-.ALPHA. (TNF-.ALPHA.) and Lethality by Lipopolysaccharide in Mice

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Plasmapheresis in severe drug-induced toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Generalised pustular drug rash.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

A case of toxic epidermal necrolysis treated with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Initial management of burns

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Measurement of involved surface area in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Toxic epidermal necrolysis. Treatment with pentoxifylline

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Neutrophilic drug eruptions

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

Elevated serum levels of interleukins 5, 6, and 10 in a patient with drug-induced exanthem caused by systemic corticosteroids

1 reference

https://api.crossref.org/works/10.1016/S0733-8635(05)70309-0

7 January 2021

10.1016/S0733-8635(05)70309-0

Identifiers

DOI

1 reference

2 August 2017

1 reference